MD Tissue Guna Tropocollagen

MD-TISSUE is an injectable medical device based on porcine-origin collagen (Type I collagen / tropocollagen — as described by the distributor’s materials). It is intended to support connective tissue and—due to its specific function—to help limit the physiological deterioration of the skin and subcutaneous connective tissue (e.g., face and neck wrinkles; firming of the connective tissue layer).

Full composition

• Collagen of porcine origin.
• Excipients: ascorbic acid, magnesium gluconate, pyridoxine hydrochloride, riboflavin, thiamine hydrochloride, NaCl, water for injection.

Form & pack sizes

Sterile 2 ml vials; available packs: 10 vials (2 ml per vial).

Aesthetic use — face & body

Face & neck (IFU-described uses)

According to the IFU, MD-TISSUE is also intended to counterbalance chrono-ageing and photo-ageing effects such as:

• face and neck wrinkles,
• firming of the subcutaneous and perivascular connective layer of the face and neck,
• altered trophicity of face/neck connective tissue induced by airborne pollutants / metabolic disorders.

Note: the IFU explicitly details face and neck. Any other body areas should only be considered based on professional qualification, assessment, and strict adherence to the IFU.

Combination within the same range (IFU)

For face and neck wrinkles and connective-tissue firming, the IFU notes MD-TISSUE may preferably be associated with MD-MATRIX (example protocol provided in the IFU).

Clinical use (per IFU)

MD-TISSUE is described as a device designed to help movement by counteracting physiological ageing of connective tissue. Main therapeutic functions include:

• barrier effect,
• lubricating action,
• mechanical support while administering other pharmacological treatments.

The IFU also lists intended uses such as:

• acting as a defensive barrier against free radicals,
• counteracting physiological ageing of connective tissue,
• soothing local pain caused by movement.

Safety notes (IFU summary)

• Contains animal-derived (porcine) collagen; for patients with known hypersensitivity, the IFU describes a spot test and monitoring.
• Possible transient redness and burning/pain at the injection site; skin cleansing/disinfection is required.
• Use immediately after opening; do not use if seal/package is damaged.

Mandatory professional-use statement

CE device. For use only by qualified professionals who have completed appropriate training and strictly in accordance with the Instructions for Use (IFU).